This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Becton Dickinson and Company Limited. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Innovations in Influenza Diagnosis by Herman Himel
Introduction
Herman Himel is an accomplished inventor based in Cary, NC (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of influenza detection. His innovative work has led to the development of a patented method that enhances the accuracy and efficiency of diagnosing influenza.
Latest Patents
Herman Himel holds a patent for a "Method and kits for the diagnosis of influenza." This patent includes embodiments that relate to combined assays. Specifically, it combines an assay for identifying influenza type A or influenza type B with an assay for determining the sensitivity of an influenza neuraminidase to an antiviral drug. This advancement is crucial for improving treatment strategies for influenza patients.
Career Highlights
Herman is currently employed at Becton Dickinson and Company Limited, a leading global medical technology company. His role at Becton Dickinson allows him to work on cutting-edge technologies that have a direct impact on public health. With a focus on innovation, he continues to push the boundaries of what is possible in medical diagnostics.
Collaborations
Herman collaborates with talented professionals in his field, including Robert L. Campbell and Kevin G. Dolan. These collaborations foster an environment of creativity and innovation, leading to the development of new diagnostic methods and technologies.
Conclusion
Herman Himel's contributions to influenza diagnostics exemplify the importance of innovation in healthcare. His patented methods not only enhance diagnostic accuracy but also pave the way for improved treatment options. His work at Becton Dickinson and his collaborations with other experts highlight the collaborative nature of scientific advancement.